# Topical Raplixa for Surgical Bleeding in Children

> **NCT02117349** · PHASE2 · TERMINATED · sponsor: **Mallinckrodt** · enrollment: 55 (actual)

## Conditions studied

- Surgical Bleeding

## Interventions

- **DRUG:** Raplixa
- **DEVICE:** Gelfoam
- **DRUG:** Rescue treatment

## Key facts

- **NCT ID:** NCT02117349
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12-04
- **Primary completion:** 2017-11-17
- **Final completion:** 2018-03-06
- **Target enrollment:** 55 (ACTUAL)
- **Why stopped:** Non-safety device related issues
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117349, "Topical Raplixa for Surgical Bleeding in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02117349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*